Introduction
Drug safety is the field concerned with identifying, evaluating, preventing, and minimizing harm associated with medicinal products. No medicine is completely free from risk in every possible circumstance. Drug safety therefore requires reliable pharmaceutical quality, evidence-based selection, appropriate clinical use, monitoring, and continuous evaluation of new safety information.
Core principles
| Principle | Description |
|---|---|
Quality assurance | Medicines should meet appropriate standards for identity, strength, purity, quality, and manufacturing consistency. |
Evidence-based use | Medicines should be used for indications supported by reliable scientific and clinical evidence. |
Appropriate patient selection | Clinical decisions should consider relevant conditions, allergies, contraindications, age, and other patient-specific factors. |
Awareness of interactions | Potential interactions with other medicines, foods, and relevant substances should be considered. |
Monitoring | Treatment outcomes and relevant adverse effects should be evaluated according to clinical needs and applicable guidance. |
Accurate information | Reliable labeling, patient information, and professional communication support safer medicine use. |
Continuous safety surveillance | New information about adverse effects and medicine-related problems should be collected and evaluated. |
Important safety concepts
| Concept | Definition |
|---|---|
Adverse drug reaction | A harmful and unintended response associated with the use of a medicinal product. |
Adverse event | An unfavorable medical occurrence following exposure to a medicinal product, which does not necessarily have a proven causal relationship with the product. |
Medication error | A preventable event that may lead to inappropriate medicine use or patient harm. |
Contraindication | A condition or situation in which a medicine should not be used because its risks are considered unacceptable. |
Pharmacovigilance | The science and activities concerned with detecting, assessing, understanding, and preventing adverse effects or other medicine-related problems. |
Medicine safety process
| Stage | Description |
|---|---|
Before authorization | Preclinical and clinical investigations evaluate quality, safety, and evidence of therapeutic benefit. |
Regulatory evaluation | Regulatory authorities assess the available evidence and determine whether a product may be authorized for specified uses. |
After authorization | Safety monitoring continues because some adverse effects may be uncommon, delayed, or difficult to identify before wider use. |
Signal detection and assessment | Potential safety signals are investigated to determine whether new evidence suggests a previously unrecognized risk. |
Risk minimization | Appropriate regulatory, labeling, educational, or clinical measures may be introduced when necessary. |
Factors influencing drug safety
Active ingredient and pharmaceutical formulation.
Medicine quality and storage conditions.
Patient age and physiological characteristics.
Genetic variation and drug metabolism.
Liver and kidney function.
Coexisting diseases.
Other medicines and relevant interactions.
Clinical indication and duration of treatment.
Accuracy of prescribing, dispensing, and administration processes.
Pharmacovigilance activities
Collection of suspected adverse reaction reports.
Evaluation of possible causal relationships.
Detection of safety signals.
Analysis of safety data from clinical and real-world sources.
Communication of new or updated safety information.
Implementation and evaluation of risk-minimization measures.
Safe medicine information
Use authoritative and current medicine information.
Check the active ingredient and product formulation.
Consider warnings, contraindications, and interactions.
Avoid relying on unsupported claims or unverified product information.
Seek qualified professional assessment when medicine-related concerns arise.
Common misconceptions
| Misconception | Correction |
|---|---|
A medicine is completely safe because it is legally authorized. | Authorization is based on an assessment of evidence for specified uses; ongoing monitoring remains necessary. |
Every adverse event is caused by the medicine taken. | An adverse event may occur after exposure without being causally related to the medicine. |
Drug safety evaluation ends after a medicine enters the market. | Post-authorization surveillance continues to identify and assess emerging safety information. |